C19H22FN3O3
359.4 g/mol
Principio activo (API)Peligro
Enrofloxacin
Enrofloxacino
CAS93106-60-6
Categoría
Principio activo (API)
Clase de Compuesto
Heterociclo
Uso Principal
Materia prima farmacéutica
Enrofloxacin is a synthetic antibacterial compound used as an active pharmaceutical ingredient. It is characterized by a quinolone core structure with fluorine and piperazine substituents, contributing to its physicochemical properties such as moderate lipophilicity and limited aqueous solubility.
manufacturing of veterinary pharmaceutical formulationsraw material for solubility-enhanced salt forms
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 93106-60-6
Compuestos relacionados
FuerteMisma estructura base
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1)
CAS112732-17-9
active pharmaceutical ingredient
SimilarEstructura similarSimilitud 0.73
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS864443-44-7
antibacterial impurity standard
ReferenciaMisma categoría
Ciprofloxacin Hydrochloride Anhydrous
CAS93107-08-5
active pharmaceutical ingredient
ReferenciaMisma categoría
2-(4-methanesulfonylphenyl)oxirane
CAS93114-06-8
Active pharmaceutical ingredient intermediate
ReferenciaMisma categoría
TACALCITOL MONOHYDRATE
CAS93129-94-3
active pharmaceutical ingredient
ReferenciaMisma categoría
Levobetaxolol
CAS93221-48-8
beta-adrenergic receptor antagonist
Referenciasame scaffold
Desfluorociprofloxacin
CAS93107-11-0
pharmaceutical impurity reference standard
Referenciasame scaffold
Gatifloxacin sesquihydrate
CAS180200-66-2
fluoroquinolone antibiotic active pharmaceutical ingredient
Referencia de Seguridad
Peligro
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identificadores
Nombre IUPAC
1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChIKey
SPFYMRJSYKOXGV-UHFFFAOYSA-N
SMILES
CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
Sinónimos (79)
- CFPQ
- ERFX
- Enrofloxacin (USAN/INN)
- Enrofloxacin (USP/INN)
- Enrofloxacin for system suitability, European Pharmacopoeia (EP)
- Enrofloxacin, European Pharmacopoeia (EP)
- Enrofloxacin, United States Pharmacopeia (USP)
- BAY VP 2674
- BAY Vp 2674;PD160788
- Baytril
- Baytril (TN)
- Baytril (veterinary)
- Baytril Soft Chewable Tablets
- ENROFLOXACIN 100
- ENROFLOXACIN [MART.]
- EnroMed
- EnroMed 100
- EnroPro 100
- EnroPro 22.7
- Enroflox
- Enroflox 100
- Enroflox Chewable Tablets
- Enroflox Injection for Dogs
- Enrofloxacin
- Enrofloxacin (Standard)
- Enrofloxacin CRS
- Enrofloxacin Flavored
- Enrofloxacin Flavored Tablets
- Enrofloxacin HCl
- Enrofloxacin base
- Enrofloxacin, >=98.0% (HPLC)
- Enrofloxacin, VETRANAL(TM)
- Enrofloxacine
- Enrofloxacine [French]
- Enrofloxacino
- Enrofloxacino [Spanish]
- Enrofloxacinum
- Enrofloxacinum [Latin]
- Enroquin
- Enroquin Flavored
- Enrosite
- Enrosite Flavored
- Enroxil
- Fluroxin
- Fluroxin Flavored
- Fluroxin for Dogs
- N-Ethylciprofloxacin
- Quellaxcin
- SolutionKits
- SolutionKits Enrofloxacin
- Tenotryl
- Zobuxa
- endrofloxicin